Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor with lower cytotoxicity than BIX-01294 [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor with lower cytotoxicity than BIX-01294 [1]. |
In vitro | CSV0C018875, at concentrations ranging from 2.5 to 20 μM over a 48-hour period, reduces H3K9me2 modification levels in histones [1]. Through Western Blot Analysis [1] conducted on HEK293 cells, with doses of 2.5 μM, 10 μM, and 20 μM, it was observed that CSV0C018875 progressively inhibits G9a enzymatic activity in a dose-dependent manner. |
分子量 | 312.79 |
分子式 | C18H17ClN2O |
CAS No. | 442150-41-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CSV0C018875 442150-41-6 Inhibitor inhibitor inhibit